This is a preview of subscription content, log in via an institution to check access.
References
The Hong Kong Cancer Registry (2005) Fast stats for female breast cancer. http://www3.ha.org.hk/cancereg/
John EM et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298(24):2869–2876. doi:10.1001/jama.298.24.2869
Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7(12):937–948. doi:10.1038/nrc2054
Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11(7):601–607
Katagiri T et al (1998) High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families. J Hum Genet 43(1):42–48. doi:10.1007/s100380050035
Wooster R et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789–792. doi:10.1038/378789a0
Song CG et al (2006) The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 132(10):617–626. doi:10.1007/s00432-006-0105-9
Zhi X et al (2002) BRCA1 and BRCA2 sequence variants in Chinese breast cancer families. Hum Mutat 20(6):474. doi:10.1002/humu.9083
Hu Z et al (2003) The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives. Hum Mutat 22(1):104. doi:10.1002/humu.9156
Sng JH et al (2000) The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer 82(3):538–542. doi:10.1054/bjoc.1999.0960
Tang NL et al (2001) Prevalence of breast cancer predisposition gene mutations in Chinese women and guidelines for genetic testing. Clin Chim Acta 313(1–2):179–185. doi:10.1016/S0009-8981(01)00671-4
Li WF et al (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110(1):99–109. doi:10.1007/s10549-008-9708-3
Chen W, et al. (2008) BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer. Breast Cancer Res Treat. doi:10.1007/s10549-008-0066-6
Zhou YZ et al (2004) Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people. Zhonghua Yi Xue Za Zhi 84(4):294–298
Ho GH et al (2000) Novel germline BRCA1 mutations detected in women in Singapore who developed breast carcinoma before the age of 36 years. Cancer 89(4):811–816. doi:10.1002/1097-0142(20000815)89:4<811::AID-CNCR13>3.0.CO;2-R
Nanda R et al (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294(15):1925–1933. doi:10.1001/jama.294.15.1925
Andrulis IL et al (2002) Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Hum Mutat 20(1):65–73. doi:10.1002/humu.10097
Sevilla C et al (2002) Testing for BRCA1 mutations: a cost-effectiveness analysis. Eur J Hum Genet 10(10):599–606. doi:10.1038/sj.ejhg.5200854
Hendrickson BC et al (2005) Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20, 000 patients from hereditary breast/ovarian cancer families. Genes Chromosomes Cancer 43(3):309–313. doi:10.1002/gcc.20189
Walsh T et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295(12):1379–1388. doi:10.1001/jama.295.12.1379
Hogervorst FB et al (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63(7):1449–1453
Montagna M et al (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12(9):1055–1061. doi:10.1093/hmg/ddg120
Tournier I et al (2004) Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 64(22):8143–8147. doi:10.1158/0008-5472.CAN-04-2467
Casilli F et al (2006) The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 43(9):e49. doi:10.1136/jmg.2005.040212
Sekine M et al (2001) Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 7(10):3144–3150
Gutierrez-Enriquez S et al (2007) Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res Treat 103(1):103–107. doi:10.1007/s10549-006-9376-8
Mazoyer S (2005) Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 25(5):415–422. doi:10.1002/humu.20169
Acknowledgments
We sincerely thank Dr. Ellen Li Charitable Foundation, The Kuok Foundation, Hong Kong Cancer Fund, National Institute of Health 1R03CA130065, and North California Cancer Center for their support. We also like to thank the research staff at Hong Kong Sanatorium and Hospital who have contributed to this project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kwong, A., Wong, L.P., Wong, H.N. et al. A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat 117, 683–686 (2009). https://doi.org/10.1007/s10549-009-0385-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-009-0385-2